Loeckie De Zwart
Johnson & Johnson (United States)(US)Janssen (Belgium)(BE)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Chronic Lymphocytic Leukemia Research, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective(2018)353 cited
- → Ibrutinib Dosing Strategies Based on Interaction Potential of CYP3A4 Perpetrators Using Physiologically Based Pharmacokinetic Modeling(2016)109 cited
- → The ontogeny of drug metabolizing enzymes and transporters in the rat(2008)86 cited
- → Stable isotope‐labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults(2015)70 cited
- → A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies(2018)47 cited
- → IMI – oral biopharmaceutics tools project – evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds(2016)42 cited
- → Blood Microsampling Using Capillaries for Drug-Exposure Determination in Early Preclinical Studies: A Beneficial Strategy to Reduce Blood Sample Volumes(2014)35 cited
- → The Application of Capillary Microsampling in Glp Toxicology Studies(2017)28 cited
- → Current Practices, Gap Analysis, and Proposed Workflows for PBPK Modeling of Cytochrome P450 Induction: An Industry Perspective(2021)28 cited
- → Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects(2019)28 cited